Avantor, Inc. $AVTR Shares Sold by Amundi

Amundi decreased its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 6.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,637,504 shares of the company's stock after selling 115,265 shares during the quarter. Amundi owned approximately 0.24% of Avantor worth $25,660,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AVTR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Avantor by 10.5% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,257 shares of the company's stock valued at $132,000 after purchasing an additional 592 shares during the last quarter. American Trust raised its position in shares of Avantor by 4.5% during the 4th quarter. American Trust now owns 15,198 shares of the company's stock valued at $320,000 after buying an additional 658 shares during the period. Nissay Asset Management Corp Japan ADV lifted its holdings in Avantor by 1.0% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 82,523 shares of the company's stock valued at $1,767,000 after acquiring an additional 857 shares during the last quarter. Portside Wealth Group LLC grew its position in Avantor by 9.0% in the first quarter. Portside Wealth Group LLC now owns 10,673 shares of the company's stock worth $173,000 after acquiring an additional 882 shares during the period. Finally, Signaturefd LLC increased its stake in Avantor by 19.8% during the first quarter. Signaturefd LLC now owns 5,470 shares of the company's stock worth $89,000 after acquiring an additional 904 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Trading Down 5.2%

NYSE:AVTR traded down $0.68 on Friday, reaching $12.33. 6,193,861 shares of the company's stock were exchanged, compared to its average volume of 10,920,702. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $8.41 billion, a price-to-earnings ratio of 12.45, a price-to-earnings-growth ratio of 1.48 and a beta of 0.98. The business has a fifty day moving average of $12.99 and a 200-day moving average of $13.90. Avantor, Inc. has a 52-week low of $10.82 and a 52-week high of $27.83.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.01). The business had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%.The firm's revenue for the quarter was down 1.1% on a year-over-year basis. During the same quarter last year, the company earned $0.25 earnings per share. As a group, analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AVTR. Evercore ISI decreased their price target on Avantor from $18.00 to $16.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. JPMorgan Chase & Co. reduced their price objective on shares of Avantor from $17.00 to $14.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Robert W. Baird reduced their price objective on shares of Avantor from $18.00 to $15.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. Jefferies Financial Group restated a "hold" rating on shares of Avantor in a report on Friday, August 1st. Finally, Barclays restated an "overweight" rating and issued a $13.00 price objective (down from $15.00) on shares of Avantor in a report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $15.50.

Insider Transactions at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,476 shares of the business's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total transaction of $39,591.64. Following the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at $627,224.52. This represents a 5.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.20% of the stock is owned by company insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.